Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age ≥ 65 Years”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02417597
What this trial is testing

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)

Who this might be right for
Hepatitis E
Xiamen Innovax Biotech Co., Ltd 600
Not applicableStudy completedNCT03578991
What this trial is testing

Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease

Who this might be right for
Patients Aged 65-85 (Both Included)Diagnosed of Mild Cognitive ImpairmentDiagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years
Parc Sanitari Pere Virgili 54
Testing effectiveness (Phase 2)Ended earlyNCT02029417
What this trial is testing

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Roswell Park Cancer Institute 2
Large-scale testing (Phase 3)Ended earlyNCT00363025
What this trial is testing

Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 465
Not applicableActive Not RecruitingNCT06804772
What this trial is testing

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo

Who this might be right for
Skin Aging
Victoria Collotta 15
Testing effectiveness (Phase 2)Ended earlyNCT02446145
What this trial is testing

Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 132
Not applicableStudy completedNCT07373860
What this trial is testing

Frailty and Chronic Pain Profiles in Patients Aged ≥65 Years

Who this might be right for
Geriatric Pain
Ankara City Hospital Bilkent 393
Testing effectiveness (Phase 2)Study completedNCT00962624
What this trial is testing

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Who this might be right for
Meningococcal Meningitis, Serogroup AMeningococcal Meningitis, Serogroup BMeningococcal Meningitis, Serogroup C+2 more
Prof. Elizabeth Miller 38
Not applicableStudy completedNCT07263828
What this trial is testing

Breath Meditation on the Older People

Who this might be right for
Individuals Over 65 Years of Age
Istanbul Aydın University 128
Testing effectiveness (Phase 2)Study completedNCT00532298
What this trial is testing

Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over

Who this might be right for
Influenza
GlaxoSmithKline 1,596
Post-approval studies (Phase 4)Study completedNCT06141655
What this trial is testing

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

Who this might be right for
Influenza
Federico Martinón Torres 134,476
Testing effectiveness (Phase 2)Study completedNCT03970733
What this trial is testing

Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis

Who this might be right for
Lyme Borreliosis
Pfizer 246
Not applicableStudy completedNCT02598115
What this trial is testing

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

Who this might be right for
AgedPatient AdmissionHospitalization
Centre Hospitalier Universitaire de Nīmes 622
Not applicableActive Not RecruitingNCT06782282
What this trial is testing

Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older

Who this might be right for
Community-Acquired Pneumonia (CAP)
Pfizer 22,234,435
Large-scale testing (Phase 3)Ended earlyNCT00976027
What this trial is testing

Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older

Who this might be right for
Influenza
Sanofi 9,172
Post-approval studies (Phase 4)WithdrawnNCT01922141
What this trial is testing

Aliskiren Study of Safety and Efficacy in Senior Hypertensives

Who this might be right for
Hypertension
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07010237
What this trial is testing

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

Who this might be right for
Sever Aplastic AnaemiaElderly (People Aged 65 or More)Immunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China 65
Post-approval studies (Phase 4)Study completedNCT02858804
What this trial is testing

EDOCH Alternating With DHAP for New Diagnosed Younger MCL

Who this might be right for
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 55
Not applicableStudy completedNCT04375241
What this trial is testing

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

Who this might be right for
Atrial Fibrillation
Diagram B.V. 2,168
Testing effectiveness (Phase 2)Study completedNCT03769194
What this trial is testing

Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

Who this might be right for
Lyme Borreliosis
Pfizer 572
Next Page